Table 4.
PA Pathogen Characteristics, n = 156 | 30-d Mortality |
90-d Mortality |
||
---|---|---|---|---|
Unadjusted OR (95% CI) |
Adjusteda OR (95% CI) |
Unadjusted OR (95% CI) |
Adjustedb OR (95% CI) |
|
Elastase activity, per SD | 1.67 (1.17-2.38) | 1.56 (1.10-2.23) | 1.62 (1.12-2.34) | 1.55 (1.08-2.22) |
Protease activity, per SD | 1.58 (1.14-2.20) | 1.46 (1.04-2.07) | 1.39 (1.01-1.92) | 1.30 (0.92-1.86) |
Biofilm production,c per SD | 1.03 (0.77-1.38) | 1.01 (0.75-1.36) | 1.10 (0.82-1.47) | 1.05 (0.77-1.44) |
MDR/XDRc | 0.98 (0.56-1.72) | 0.83 (0.39-1.78) | 0.86 (0.51-1.48 | 0.72 (0.34-1.51) |
Polymicrobiald | 0.41 (0.23-0.73) | 0.57 (0.27-1.22) | 0.66 (0.39-1.12) | 0.91 (0.44-1.87) |
A logistic regression model was used to determine the association between PA pathogen factors and 30-d and 90-d mortality in early samples collected between 0 and 3 days from the index ICU admission date. The early and late subgroups were determined using a finite mixture model. CCI = Charlson Co-morbidity Index; MDR = multidrug-resistant; mSOFA = modified sequential organ failure assessment score; XDR = extensively drug resistant.
The 30-d mortality model was adjusted for age, sex, and mSOFA.
The 90-d mortality model was adjusted for age, sex, mSOFA, and CCI. P < .05 are in bold.
n = 154 for Biofilm production and n = 153 for MDR/XDR.
n = 154 for polymicrobial.